European Bioanalysis Forum Workshop, Lisbon, Portugal, September 2016: At the recent European Bioanalysis Forum Focus Workshop, 'current analysis of immunogenicity: best practices and regulatory hurdles', several important challenges facing the bioanalytical community in relation to immunogenicity assays were discussed through a mixture of presentations and panel sessions. The main areas of focus were the evolving regulatory landscape, challenges of assay interferences from either drug or target, cut-point setting and whether alternative assays can be used to replace neutralizing antibody assays. This workshop report captures discussions and potential solutions and/or recommendations made by the speakers and delegates.
CITATION STYLE
Goodman, J., Cowen, S., Devanarayan, V., Egging, D., Emrich, T., Golob, M., … Timmerman, P. (2018). Feedback from the European Bioanalysis Forum: Focus workshop on current analysis of immunogenicity: Best practices and regulatory hurdles. In Bioanalysis (Vol. 10, pp. 197–204). Future Medicine Ltd. https://doi.org/10.4155/bio-2017-4971
Mendeley helps you to discover research relevant for your work.